"The Norman Fixel Institute for Neurological Diseases is home to scientists and clinicians at UF Health who are working on neurological disorders that afflict millions of people across the globe. These conditions include Parkinson’s, dystonia and other movement disorders, Alzheimer’s disease and dementias, concussion, traumatic brain injury, and neuromuscular disorders like amyotrophic lateral sclerosis, also known as ALS, or Lou Gehrig’s disease. The Institute is a cornerstone of the university’s aspiration to help create history’s healthiest generation through precision health, the elimination of health disparities and the advancement of therapies related to the brain and neuromuscular and mental health."

During the past decade, Norman Fixel Institute for Neurological Diseases conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norman Fixel Institute for Neurological Diseases" #1 sponsor was "University of Florida" with 3 trials, followed by "Amylyx Pharmaceuticals Inc." with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored, "NeuroDerm Ltd." with 1 trials sponsored and "Theravance Biopharma" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norman Fixel Institute for Neurological Diseases" #1 collaborator was "Parkinson's Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Norman Fixel Institute for Neurological Diseases" are "Parkinson Disease" (3 trials), "ALS" (1 trials), "Dystonia" (1 trials), "Essential Tremor" (1 trials) and "Ketosis" (1 trials). Many other conditions were trialed in "Norman Fixel Institute for Neurological Diseases" in a lesser frequency.

Most popular intervention types in "Norman Fixel Institute for Neurological Diseases" are "Drug" (4 trials), "Other" (3 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AMX0035" (1 trials), "Carbidopa and Levodopa 25mg/100mg" (1 trials), "Frequency of physical therapy sessions" (1 trials) and "Ketone Ester Elite endurance Nutrition Drink" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norman Fixel Institute for Neurological Diseases" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Norman Fixel Institute for Neurological Diseases". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Norman Fixel Institute for Neurological Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Norman Fixel Institute for Neurological Diseases, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".